Skip to main content

Recommended

Services

    PI Leaflets

      Pages

        No results found.

        Quick guide to urgency of nephrology referral

        Immediate review

        Refer to A and E for initial exclusion of obstructive cause. Contact on call renal team for urgent review as below:

        • acute kidney injury stage 3 (after exclusion of urinary tract obstruction if lower tract symptoms), requires discussion with on call renal team.
        • newly detected estimated glomerular filtration rate (eGFR) <15ml/min (after exclusion of obstruction if lower tract symptoms)
        • hyperkalaemia, serum potassium >6.5mmol/L (after exclusion of artefactual and treatable causes)
        • accelerated or malignant phase hypertension with suspicion of underlying kidney disease

        Queen Elizabeth Hospital Birmingham (QEHB) on-call registrar phone:

        Birmingham Heartlands Hospitals (BHH) on-call registrar or consultant is available via switchboard.

        Direct referral to nephrology services via A and R

        • Nephrotic syndrome – albumin to creatinine ratio (ACR) or protein creatinine ration (PCR) >300mg/mmol) with albumin <30g/L (urgent appointment required)
        • Possible multisystem disease (e.g. systemic lupus erythematosus (SLE), systemic vasculitis) with evidence of kidney disease (urgent appointment required)
        • Five-year risk of needing renal replacement therapy of greater than 5%* (A and G may be all that is required, if marginal benefit to patient and already on optimal medication)
        • Urine ACR of >70mg/mmol (unless known to be caused by diabetes and already on appropriate management) (routine review)
        • ACR of >30mg/mmol together with non-visible haematuria
        • **sustained decrease in eGFR of >25% or >15ml/min AND a change in chronic kidney disease (CKD) category within 12 months
        • Known or suspected rare or genetic cause of CKD
        • Suspected renal artery stenosis
        • Uncontrolled (>150/90) BP despite 4 agents at therapeutic doses in a patient with CKD (non CKD patients refer directly to hypertension service via separate A and R)

        Last reviewed: 05 September 2024